| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 43.03× | 43.03× | 38.86× | 30.02× | 28.50× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 1.01× | 1.04× | 1.11× | 1.26× | 1.50× | ||
| 0.42× | 0.42× | 0.40× | 0.40× | 0.39× | ||
| 2.41× | 2.41× | 3.14× | −4.13× | 6.94× | ||
| 0.62× | 0.62× | 0.85× | −1.27× | 1.44× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 28.50 | 30.02 | 38.86 | 43.03 | 43.03 | |
| Working Capital Turnover | 1.50 | 1.26 | 1.11 | 1.04 | 1.01 | |
| Asset Turnover | 0.39 | 0.40 | 0.40 | 0.42 | 0.42 | |
| Cash Conversion (CFO/Net Income) | 6.94 | -4.13 | 3.14 | 2.41 | 2.41 | |
| CFO/EBITDA | 1.44 | -1.27 | 0.85 | 0.62 | 0.62 |